Simona Fikhman
Surgical · Studio City, CANPI 1477979656
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,064 of the $11,928 with a category attached, or 76.0%. 31 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 24.9% of the total. Reporting peaked in 2022 at $4,115 and has fallen 53.7% since, to $1,905 in 2025. Among surgical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $33.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$3K
- AbbVie$1K
- Novartis$1K
- Sanofi$800
- Mayne Pharma Commercial LLC$787
- Arcutis Biotherapeutics, Inc.$776
- plus $4K from 25 others
What the payments were for
- Consulting fees$2,00017%
- Speaking & faculty fees$5004%
- Travel & lodging$2642%
- Food & beverage$9,06476%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 24 | $2,975 |
| AbbVie | 69 | $1,251 |
| Novartis | 57 | $1,144 |
| Sanofi | 22 | $800 |
| Mayne Pharma Commercial LLC | 26 | $787 |
| Arcutis Biotherapeutics, Inc. | 16 | $776 |
| LEO Pharma Inc. | 28 | $554 |
| UCB, Inc. | 15 | $505 |
| Galderma Laboratories, L.p. | 14 | $406 |
| Lilly USA, LLC | 11 | $395 |
| Johnson & Johnson | 16 | $389 |
| Regeneron Healthcare Solutions, Inc. | 10 | $354 |
| Dermavant Sciences, Inc. | 8 | $201 |
| Incyte Corporation | 8 | $189 |
| EPI Health, LLC | 4 | $162 |
| Amgen | 7 | $162 |
| Revance Therapeutics, Inc. | 2 | $156 |
| Organon | 1 | $140 |
| Pfizer | 6 | $107 |
| Journey Medical Corporation | 2 | $102 |
| E.r. Squibb & Sons, L.L.C. | 1 | $61 |
| Janssen Scientific Affairs, LLC | 1 | $60 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $38 |
| Almirall LLC | 1 | $38 |
| Botanix SB Inc | 2 | $35 |
| VYNE Pharmaceuticals Inc. | 2 | $33 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $25 |
| Krystal Biotech Inc | 1 | $24 |
| Biofrontera Inc. | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Merz North America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,928 in reported general payments places this provider in the 95th percentile of 729 surgical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 27 | $16,918 |
| Ivermectin | 15 | $5,908 |
| Clobetasol Propionate | 14 | $2,756 |
| Metronidazole | 11 | $1,653 |
| Betamethasone Dipropionate | 42 | $1,412 |
| Fluocinolone Acetonide | 41 | $1,410 |
| Doxycycline Hyclate | 70 | $1,048 |
| Ketoconazole | 68 | $855 |
| ValacyclovirValacyclovir Hcl | 23 | $525 |
| Ciclopirox | 17 | $495 |
| Triamcinolone Acetonide | 86 | $280 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 14 | $241 |
| Nystatin | 20 | $212 |
| NyamycNystatin | 13 | $152 |
Paid to pharmacies, not to this prescriber.
Other surgical in Studio City
- Jessica KramerStudio City$15K
- Lauren AmicoVista$989K
- Cheyanne MallasWest Hollywood$199K
- Laura PietrzakMarina del Rey$63K
- Jane HartiganSanta Rosa$27K
- Kenny NgoPalo Alto$25K
- Crispin MarRancho Santa Margarita$23K
- Robert FrostRancho Santa Margarita$22K
- Audie LeeSan Francisco$21K
- Gregory BrunetSanta Barbara$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.